Icodextrin and its preparation method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HUAREN PHARMACEUTICAL CO LTD
- Publication Date
- 2015-08-26
Abstract
Description
technical field
[0001] The invention relates to the field of medicine preparation, in particular to an icodextrin and a preparation method thereof. Background technique
[0002] Icodextrin is the main active ingredient in icodextrin peritoneal dialysis solution, which is used for the treatment of end-stage renal disease. It was first developed by the American ATTELION company and was approved by the FDA in 2002 by Baxter Medical. And Baxter's new peritoneal dialysis fluid, Icodextrin, was approved for marketing in Japan on July 18, 2003. Extraneal has been approved for marketing in 36 countries, including Taiwan and the United States recently. But there is only one simple sentence about the preparation of icodextrin: starch is hydrolyzed under the action of acid to prepare icodextrin. There is currently no patent on the preparation and production process of icodextrin API. In the existing literature about icodextrin peritoneal dialysis solution, respectively described: a k...